Latest News

Negative Effect of Deferiprone Points to Impact of Iron Lowering in Alzheimer Disease
Negative Effect of Deferiprone Points to Impact of Iron Lowering in Alzheimer Disease

November 20th 2024

Over a 12-month treatment period, patients on deferiprone demonstrated decreased blood ferritin and hippocampal QSM but caused accelerated cognitive decline and increased regional brain atrophy.

Sumatriptan Demonstrates Therapeutic Potential in Post-Traumatic Headache in Phase 2 Pilot Study
Sumatriptan Demonstrates Therapeutic Potential in Post-Traumatic Headache in Phase 2 Pilot Study

November 20th 2024

Barry Greene  (Credit: X)
Huntington Agent SAGE-718 to be Discontinued Following Disappointing Phase 2 DIMENSION Trial Results

November 20th 2024

Triheptanoin Shows No Significant Effect on Movement Disorder Events in Glut1 Deficiency Syndrome
Triheptanoin Shows No Significant Effect on Movement Disorder Events in Glut1 Deficiency Syndrome

November 20th 2024

NeuroVoices: Charbel Moussa, PhD, MBBS, on Therapeutic Potential of Nilotinib in Dementia With Lewy Bodies
NeuroVoices: Charbel Moussa, PhD, MBBS, on Therapeutic Potential of Nilotinib in Dementia With Lewy Bodies

November 20th 2024

Coverage of the 17th Clinical Trials on Alzheimer's Disease Conference Conference

Get direct access to expert insight and perspective, and all the coverage of the key data presentations, straight from the conference floor in Madrid.

CTAD 2024

Conference Coverage

View All
NeuroVoices: Charbel Moussa, PhD, MBBS, on Therapeutic Potential of Nilotinib in Dementia With Lewy Bodies
NeuroVoices: Charbel Moussa, PhD, MBBS, on Therapeutic Potential of Nilotinib in Dementia With Lewy Bodies

November 20th 2024

Challenges in Identifying Optimal Candidates for Muscular Dystrophy Gene Therapies: Melissa Spencer, PhD
Challenges in Identifying Optimal Candidates for Muscular Dystrophy Gene Therapies: Melissa Spencer, PhD

November 19th 2024

Need for Better, More Specific Delivery Methods for Gene Therapies in Muscular Dystrophy: Melissa Spencer, PhD
Need for Better, More Specific Delivery Methods for Gene Therapies in Muscular Dystrophy: Melissa Spencer, PhD

November 18th 2024

Lawrence Robinson, MD
Educational Benefits of Flipped Classrooms in Teaching Settings: Lawrence Robinson, MD

November 13th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.